Gene Therapy of Multiple Sclerosis Using Interferon β-Secreting Human Bone Marrow Mesenchymal Stem Cells

Interferon-beta (IFN-β), a well-established standard treatment for multiple sclerosis (MS), has proved to exhibit clinical efficacy. In this study, we first evaluated the therapeutic effects for MS using human bone marrow-derived mesenchymal stem cells (hBM-MSCs) as delivery vehicles with lesion-tar...

詳細記述

保存先:
書誌詳細
主要な著者: Ryu, Chung Heon, Park, Kwang Ywel, Hou, Yun, Jeong, Chang Hyun, Kim, Seong Muk, Jeun, Sin-Soo
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654641/
https://ncbi.nlm.nih.gov/pubmed/23710456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/696738
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料